范可尼贫血组蛋白A抗体

英文名称    FANCA    

中文名称    范可尼贫血组蛋白A抗体    

别    名    FA 1; FA; FA H; FA1; FAA; FACA; FAH; Fanca; FANCA_HUMAN; FANCH; Fanconi anemia complementation group A; Fanconi anemia complementation group H; Fanconi anemia group A protein; Fanconi anemia type 1; MGC75158; Protein FACA.    

说 明 书    0.2ml      

研究领域    细胞生物  发育生物学  细胞周期蛋白      

抗体来源    Rabbit    

克隆类型    Polyclonal    

交叉反应    Human, Mouse, Rat, Chicken, Rabbit,     

产品应用    WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 范可尼贫血组蛋白A抗体（石蜡切片需做抗原修复） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.    

分 子 量    160kDa    

细胞定位    细胞核 细胞浆     

性    状    Lyophilized or Liquid    

浓    度    1mg/1ml    

免 疫 原    KLH conjugated synthetic peptide derived from human FANCA    

亚    型    IgG    

纯化方法    affinity purified by Protein A    

储 存 液    Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4    

保存条件    Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.    

范可尼贫血组蛋白A抗体产品介绍    background:

Fanconi anemia (FA) is an autosomal recessive disorder characterized by bone marrow failure, birth defects and chromosomal instability. At the cellular level, FA is characterized by spontaneous chromosomal breakage and a unique hypersensitivity to DNA cross-linking agents. At least eight complementation groups (A-G) have been identified and six FA genes (for subtypes A, C, D2, E, F and G) have been cloned. The FA proteins lack sequence homologies or motifs that could point to a molecular function. The cellular accumulation of FA proteins, including FANCA and FANCG, is subject to regulation by TNF alpha signaling. Phosphorylation of FANC (Fanconi anemia complementation group) proteins is thought to be important for the function of the FA pathway. FANCA, also known as FACA and FANCH, associates with the Brm-related gene 1 (BRG1) product, a subunit of the SWI/SNF complex which remodels chromatin structure through a DNA-dependent ATPase activity. FANCA is mainly expressed in lymphoid tissues, testis and ovary. The amino-terminal region of the FANCA protein is required for FANCG binding, FANCC binding, nuclear localization and functional activity of the complex. The human FANCA gene maps to chromosome 16q24.3 and encodes a 1,455 amino acid protein.

Function:
DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be involved in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability

Subunit:
Belongs to the multisubunit FA complex composed of FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL/PHF9 and FANCM. The complex is not found in FA patients. In complex with FANCF, FANCG and FANCL, but not with FANCC, nor FANCE, interacts with HES1; this interaction may be essential for the stability and nuclear localization of FA core complex proteins. The complex with FANCC and FANCG may also include EIF2AK2 and HSP70. Interacts with FAAP20/C1orf86; interaction is direct.

Subcellular Location:
Nucleus. Cytoplasm. Note=The major form is nuclear. The minor form is cytoplasmic. 

Post-translational modifications:
Phosphorylated upon DNA damage, probably by ATM or ATR. Phosphorylation is required for the formation of the nuclear complex. Not phosphorylated in cells derived from groups A, B, C, E, F, G, and H.

DISEASE:
Defects in FANCA are a cause of Fanconi anemia (FA) [MIM:227650]. FA is a genetically heterogeneous, autosomal recessive disorder characterized by progressive pancytopenia, a diverse assortment of congenital malformations, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage), and defective DNA repair.

Similarity:
Nucleus. Cytoplasm. The major form is nuclear. The minor form is cytoplasmic.

Database links:
UniProtKB/Swiss-Prot: O15360.2

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.    

范可尼贫血组蛋白A抗体

hz-3523R PBK/TOPK  PDZ连接激酶/T-LAK细胞源蛋白激酶抗体

hz-3326R Phospho-PBK/TOPK(Thr9)  磷酸化PDZ连接激酶/T-LAK细胞源蛋白激酶抗体

hz-3539R Paxillin  桩蛋白Paxillin抗体

hz-3352R Phospho-Paxillin (Tyr118)  磷酸化桩蛋白Paxillin抗体

hz-3744R Phospho-Paxillin(Tyr31)  磷酸化桩蛋白Paxillin抗体

hz-5548R Phospho-Paxillin(Tyr88)  磷酸化桩蛋白Paxillin抗体

hz-5549R Phospho-Paxillin(Ser83)  磷酸化桩蛋白Paxillin抗体

hz-5550R Phospho-Paxillin(Ser178)  磷酸化桩蛋白Paxillin抗体

hz-1159R P-cadherin  P-钙粘附分子抗体

hz-3675R R-cadherin/Cadherin 4  R-钙粘附分子抗体

hz-1617R LI-cadherin  肝肠钙粘连蛋白抗体

hz-5000R PCB  丙酮酸羧化酶抗体

hz-0754R PCNA  增殖细胞核抗原抗体

hz-4197R PLB/phospholamban  心脏磷蛋白抗体

hz-0491R PCNA  增殖细胞核抗原抗体

hz-1608R PDCD4  凋亡相关蛋白4抗体

hz-2006R PCNA-Proliferation Marker  增殖细胞核抗原抗体

hzm-2006M PCNA(1C11)  小鼠增殖细胞核抗原单克隆抗体

hz-1333R TFAR19/PDCD5  凋亡相关蛋白5抗体

hz-2007R PCNA [Proliferation Marker]  增殖细胞核抗原抗体

hz-2215R phosphos-PCNA (Tyr211)  磷酸化增殖细胞核抗原抗体

hz-1345R PCX/PODXL  足细胞特异蛋白抗体

hz-2384R PDE4A  磷酸二酯酶4A抗体

hz-1325R PDE4D  磷酸二酯酶4D抗体

hz-1867R PD-1/CD279  程序性死亡1抗体

hz-2349R PDE5A  磷酸二酯酶5A抗体

hz-1866R PDEF/SPDEF  上皮特异性ETs转录因子抗体

hz-0196R PDGF-A  血小板源性生长因子-A抗体

hz-5707R TUSC2  血小板源性生长因子A相关蛋白2抗体

hz-0185R PDGF-B  血小板源性生长因子-B抗体

hz-1316R PDGF-BB  血小板源性生长因子-BB抗体

hz-0231R PDGFRA  血小板源性生长因子受体A抗体(PDGFRα)

hz-3318R Phospho-PDGFRA(Tyr1018)  磷酸化血小板源性生长因子受体-α抗体

hz-3319R Phospho-PDGFRA(Tyr754)  磷酸化血小板源性生长因子受体-α抗体